<?xml version="1.0" encoding="UTF-8"?>
<ref id="tca13424-bib-0008">
 <label>8</label>
 <mixed-citation publication-type="journal" id="tca13424-cit-0008">
  <string-name>
   <surname>Sgambato</surname>
   <given-names>A</given-names>
  </string-name>, 
  <string-name>
   <surname>Casaluce</surname>
   <given-names>F</given-names>
  </string-name>, 
  <string-name>
   <surname>Maione</surname>
   <given-names>P</given-names>
  </string-name>, 
  <string-name>
   <surname>Gridelli</surname>
   <given-names>C</given-names>
  </string-name>. 
  <article-title>Targeted therapies in non‐small cell lung cancer: A focus on ALK/ROS1 tyrosine kinase inhibitors</article-title>. 
  <source xml:lang="en">Expert Rev Anticancer Ther</source>
  <year>2018</year>; 
  <volume>18</volume>: 
  <fpage>71</fpage>–
  <lpage>80</lpage>.
  <pub-id pub-id-type="pmid">29187012</pub-id>
 </mixed-citation>
</ref>
